Scarica l'app Stockscreener
0.3588
1.93%
0.0068
Pre-mercato:
.33
-0.0288
-8.03%
Precedente Chiudi:
$0.352
Aprire:
$0.336
Volume 24 ore:
188.46K
Relative Volume:
0.62
Capitalizzazione di mercato:
$3.50M
Reddito:
$11.26M
Utile/perdita netta:
$-3.09M
Rapporto P/E:
-0.895
EPS:
-0.4009
Flusso di cassa netto:
$-1.49M
1 W Prestazione:
-5.58%
1M Prestazione:
-13.58%
6M Prestazione:
-68.80%
1 anno Prestazione:
-85.38%
Intervallo 1D:
$0.3341
$0.3632
Intervallo di 1 settimana:
$0.3284
$0.3911
Portata 52W:
$0.3001
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
Nome
Nexgel Inc
Settore
Industria
Telefono
215 702-8550
Indirizzo
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.3588 | 3.78M | 11.26M | -3.09M | -1.49M | -0.4009 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nexgel Inc Borsa (NXGL) Ultime notizie
NEXGEL (NXGL) terminates CEO and launches broad strategic review - Stock Titan
NEXGEL Names Brian Kieser Interim CEO, Launches Strategic Review - citybiz
symbol__ Stock Quote Price and Forecast - CNN
Nexgel, Inc. Forms Special Committee to Oversee Comprehensive Strategic Review and Value Creation - marketscreener.com
NEXGEL Appoints Brian Kieser To Replace CEO Adam Levy Effective August 21 - TradingView
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE - GlobeNewswire
NexGel Files to Register 15.25 Million Shares From Note Conversions - marketscreener.com
NexGel (NXGL) Earnings Report: The EPS Result Is Below Expectation in the Latest Session; Post-Earnings: Shares Move 5.05% Up in the Latest ReadingEarnings Call Transcript - dars.gov.et
NXGL | NexGel, Inc Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
NexGel (NXGL) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Available Record; Share Response: Shares Finish 5.05% Up in Latest TradingEarnings Season Outlook - dars.gov.et
NexGel (NXGL) Earnings Brief: EPS Does Not Reach the Reported Estimate at the Close; Session Reaction - vinanet.vn
NexGel (NXGLW) Session Check: Records a 33.33% Increase to $0.02 in the Latest Reading; Level Check: the Session Ends Within the Reported Technical Boundaries in the Latest SessionCumulative Volume - vinanet.vn
Nexgel earnings missed by $0.30, revenue topped estimates - Investing.com Canada
Dow Falls 150 Points; NY Empire State Manufacturing Index Rises In August - Sahm
Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition - TipRanks
NexGel Q2 FY26 gross profit falls 11.84% to $1.11 million; revenue rises 27.8% to $3.69 million - Bitget
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp - Yahoo Finance
NexGel Q2 Loss Widens Sharply on $2.2M Interest and Derivative Charges - Minichart
Form 8K Nexgel Inc For: 17 August By Investing.com - Investing.com Nigeria
NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continue - TradingView
NEXGEL Q2 2026: Revenue $3.69M, Net Loss $2.87M as Company Transitions Post-Acquisition - TradingView
NEXGEL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
NEXGEL Reports Second Quarter 2026 Financial Results - The Manila Times
NEXGEL's Surgical Business Has a $795,000 Backlog—What's Holding It Up? - Stock Titan
NXGL Q2'26 Earnings: EPS estimate is (0.12) USD - TradingView
NEXGEL, INC. Q2 2026: Revenue $3.69M, EPS $(0.40) — 10-Q Summary - TradingView
NexGel (NXGL) pushes back Q2 report, cites audit review - Stock Titan
NexGel (NXGL) issues going‑concern warning after Q2 loss - Stock Titan
NexGel (NXGL) plans big share authorization boost and reverse split to protect Nasdaq listing - Stock Titan
NEXGEL, Inc. (NASDAQ:NXGL): Are Analysts Optimistic? - simplywall.st
NexGel Inc (NXGL) Dips 3.95% to $0.36, Testing Key Support ZoneCalendar Spread Trade - Vinanet
Nexgel Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
NexGel Inc (NXGL) Surges 15% as Micro-Cap Healthcare Stock Approaches Key ResistanceSupply Zone - dars.gov.et
NexGel shareholders constrain structural changes at annual meeting - The Globe and Mail
NexGel, Inc Revenue Breakdown – BOATS:NXGLW - TradingView
NXGL Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerSegment Revenue Breakdown - vinanet.vn
NXGL Q1 2026 Earnings: EPS Loss Widens Sharply Beyond Estimates; Stock DeclinesFinancial Data - dars.gov.et
NexGel Updates CEO Employment Terms and Incentive Plan - The Globe and Mail
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Misses Estimates as Losses WidenEBITDA Analysis - dars.gov.et
Form 4 Nexgel Inc For: 29 July By Investing.com - Investing.com Canada
NexGel Inc (NXGL) Holds Near Key Support After Marginal DeclineLow Vol ETF - vinanet.vn
NexGel, Inc Revenue Breakdown – NASDAQ:NXGL - tradingview.com
NXGL|Nexgel Inc|Price:0.436|Chg%:-0.003 - TradingKey
Nexgel Inc (NXGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGL) Balance Sheet - TradingKey
Nexgel Inc (NXGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGL) Cash Flow - TradingKey
NexGel, Inc Revenue Breakdown – NASDAQ:NXGLW - TradingView
Nexgel Inc (NXGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc Azioni (NXGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nexgel Inc Azioni (NXGL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer |
Jun 23 '26 |
Sale |
0.59 |
5,000 |
2,967 |
322,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 11 '26 |
Sale |
0.61 |
3,000 |
1,841 |
333,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 04 '26 |
Sale |
0.59 |
3,000 |
1,781 |
339,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 08 '26 |
Sale |
0.55 |
3,000 |
1,641 |
336,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 01 '26 |
Sale |
0.59 |
2,000 |
1,172 |
342,692 |
| Levy Adam R. | Chief Executive Officer |
May 28 '26 |
Sale |
0.61 |
7,000 |
4,241 |
347,692 |
| Levy Adam R. | Chief Executive Officer |
May 29 '26 |
Sale |
0.60 |
3,000 |
1,801 |
344,692 |
| Levy Adam R. | Chief Executive Officer |
May 27 '26 |
Sale |
0.60 |
3,000 |
1,792 |
354,692 |
1.40%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):